The substances we treat at The Grove Estate are alcohol, opioids (e.g., heroin, prescription painkillers), benzodiazepines (e.g., Xanax, Valium), and stimulants (e.g., cocaine, meth). In 2024, 9% of urban and 7% of rural Indiana overdose decedents had evidence of receiving substance use disorder treatment, according to the Indiana Department of Health’s Fatal Overdose and Suicide Report, 2024. The four substance groups treated at The Grove Estate are:
Alcohol
Alcohol withdrawal carries a seizure risk and is managed inside the residential program with registered nurses on site 24 hours, rather than at a separate facility. Residential alcohol rehab covers medication management, individual counseling and behavioral health programming matched to the level of dependence.
Opioids
Opioids were the drug class most often involved in Indiana’s fatal overdoses in 2024, at approximately 69%, according to the Indiana Department of Health’s Fatal Overdose and Suicide Report, 2024. Opioid addiction rehab addresses physical dependence on substances such as heroin, fentanyl, oxycodone and hydrocodone, and the muscle pain, abdominal cramping, nausea, sweating and insomnia that withdrawal produces.
Benzodiazepines
Benzodiazepines were detected in 8.5% of Indiana overdose deaths in 2024, up from 8.1% in 2023, according to the Indiana Department of Health’s Fatal Overdose and Suicide Report, 2024. Benzodiazepine addiction accounts for a smaller share of treatment admissions in Indiana than opioids or methamphetamine, but it remains a serious concern because of its role in polysubstance use and overdose risk.
Stimulants
Psychostimulants excluding cocaine, a category that includes methamphetamine, were involved in 37.8% of Indiana overdose deaths in 2024, and cocaine in 21.3%, according to the Indiana Department of Health’s Fatal Overdose and Suicide Report, 2024. The Grove Estate runs cocaine rehab and detox and meth addiction treatment as separate programs.